Actelion Pharmaceuticals Ltd.  - logo

Actelion Pharmaceuticals Ltd. - Company & Market Research Reports

Actelion Pharmaceuticals develops drugs for pulmonary arterial hypertension treatments that cover the spectrum of diseases ranging from WHO functional class (FC) II through to FC IV, with oral, inhaled, and intravenous medications. Actelion has operative affiliates in over 30 countries. The company was founded in 1997 and is based in Allschwil, Switzerland. Actelion Pharmaceuticals Ltd. operates as a subsidiary of Actelion Ltd.


Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market - Product Thumbnail Image

Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market

  • Report
  • 197 Pages
From
Dry Powder Inhalers: Products, Therapeutics, Players and Forecasts - Product Thumbnail Image

Dry Powder Inhalers: Products, Therapeutics, Players and Forecasts

  • Report
  • 160 Pages
From
Transdermal Drug Delivery Market: By Technology; By Application, Pain Management, Cardiovascular, Others & By Region - Forecast 2017-2022 - Product Thumbnail Image

Transdermal Drug Delivery Market: By Technology; By Application, Pain Management, Cardiovascular, Others & By Region - Forecast 2017-2022

  • Report
  • 169 Pages
From
Pediatric Drugs and Vaccines - Global Strategic Business Report - Product Thumbnail Image

Pediatric Drugs and Vaccines - Global Strategic Business Report

  • Report
  • 431 Pages
From
The 2018-2023 World Outlook for Pediatric Drugs and Vaccines - Product Thumbnail Image

The 2018-2023 World Outlook for Pediatric Drugs and Vaccines

  • Report
  • 293 Pages
Psoriasis - Oral and Novel Biologics to Change Future Market Dynamics - Product Thumbnail Image

Psoriasis - Oral and Novel Biologics to Change Future Market Dynamics

  • Report
  • 56 Pages
From
Transplantation Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Transplantation Drug Development Pipeline Review, 2017

  • Report
  • 242 Pages
From
Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016 - Product Thumbnail Image

Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016

  • Clinical Trials
  • 205 Pages
From
Oncology Drug Report - Adcetris - Brentuximab Vedotin - 2011-2015 analysis; 2016-2021 Expectations - Product Thumbnail Image

Oncology Drug Report - Adcetris - Brentuximab Vedotin - 2011-2015 analysis; 2016-2021 Expectations

  • Report
  • 75 Pages
From
Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) - Pipeline Review, H1 2018 - Product Thumbnail Image

Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) - Pipeline Review, H1 2018

  • Report
  • 90 Pages
From
Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H1 2018 - Product Thumbnail Image

Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H1 2018

  • Report
  • 54 Pages
From
Sphingosine 1-Phosphate Receptor 1 (S1P Receptor 1 or Endothelial Differentiation G-Protein Coupled Receptor 1 or Sphingosine 1-Phosphate Receptor Edg-1 or CD363 or S1PR1 or CHEDG1 or EDG1) - Pipeline Review, H1 2016 - Product Thumbnail Image

Sphingosine 1-Phosphate Receptor 1 (S1P Receptor 1 or Endothelial Differentiation G-Protein Coupled Receptor 1 or Sphingosine 1-Phosphate Receptor Edg-1 or CD363 or S1PR1 or CHEDG1 or EDG1) - Pipeline Review, H1 2016

  • Report
  • 71 Pages
From
Prostaglandin D2 Receptor 2 (Chemoattractant Receptor-Homologous Molecule Expressed On Th2 Cells or G-Protein Coupled Receptor 44 or CD294 or DP2 or PTGDR2) - Pipeline Review, H1 2016 - Product Thumbnail Image

Prostaglandin D2 Receptor 2 (Chemoattractant Receptor-Homologous Molecule Expressed On Th2 Cells or G-Protein Coupled Receptor 44 or CD294 or DP2 or PTGDR2) - Pipeline Review, H1 2016

  • Report
  • 59 Pages
From
DP2 Receptor (G Protein-Coupled Receptor 44 or Chemoattractant Receptor-Homologous Molecule On Th2 Cells (CRTH2)) Antagonist -Pipeline Insight, 2018 - Product Thumbnail Image

DP2 Receptor (G Protein-Coupled Receptor 44 or Chemoattractant Receptor-Homologous Molecule On Th2 Cells (CRTH2)) Antagonist -Pipeline Insight, 2018

  • Drug Pipelines
  • 60 Pages
From
Chronic Plaque Psoriasis - Pipeline Review, H1 2015 - Product Thumbnail Image

Chronic Plaque Psoriasis - Pipeline Review, H1 2015

  • Report
  • 109 Pages
From
Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance - Product Thumbnail Image

Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance

  • Report
  • 177 Pages
From
Global Cardiovascular Disease Drugs Market to 2023 - Expiries, Acquisitions and New Products for Deep Vein Thrombosis, Pulmonary Arterial Hypertension and Dyslipidemia to Shake-Up the Competitive Landscape - Product Thumbnail Image

Global Cardiovascular Disease Drugs Market to 2023 - Expiries, Acquisitions and New Products for Deep Vein Thrombosis, Pulmonary Arterial Hypertension and Dyslipidemia to Shake-Up the Competitive Landscape

  • Report
  • 228 Pages
From
Fabry's Disease Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments - Product Thumbnail Image

Fabry's Disease Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments

  • Report
  • 102 Pages
From
2018 Diarrhea Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Diarrhea Drug Development- Pipeline Analysis Report

  • Report
  • 70 Pages
From
2018 Trigeminal Neuralgia Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Trigeminal Neuralgia Drug Development- Pipeline Analysis Report

  • Report
  • 35 Pages
From
Loading Indicator
adroll